pd 98059 has been researched along with MS (Multiple Sclerosis) in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Attia, SM | 2 |
Ahmad, SF | 2 |
Nadeem, A | 2 |
Attia, MSM | 1 |
Ansari, MA | 2 |
Alsaleh, NB | 1 |
Alasmari, AF | 2 |
Al-Hamamah, MA | 1 |
Alanazi, A | 1 |
Alshamrani, AA | 2 |
Bakheet, SA | 2 |
Harisa, GI | 1 |
Shahid, M | 1 |
Al-Mazroua, HA | 1 |
Alomar, HA | 1 |
AsSobeai, HM | 1 |
2 other studies available for pd 98059 and MS (Multiple Sclerosis)
Article | Year |
---|---|
The small molecule Erk1/2 signaling pathway inhibitor PD98059 improves DNA repair in an experimental autoimmune encephalomyelitis SJL/J mouse model of multiple sclerosis.
Topics: Animals; Antineoplastic Agents; DNA; DNA Repair; Encephalomyelitis, Autoimmune, Experimental; Mice; | 2023 |
MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; | 2023 |